Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Neogenomics Inc
NASDAQ:NEO
Neogenomics Inc
NASDAQ:NEO
Price:
16.02
USD
-3.14%
Market Closed
Market Cap:
$2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
NEO Price Forecast
Based on 11 analysts
Based on 11 analysts
+40% Upside
from
$16.02
today
Neogenomics Inc (NEO)’s 12-month stock price forecast through November 2027 has a consensus target of $22.44, implying 40% upside. The forecast is based on price targets from 11 Wall Street analysts.
NEO Analyst Rating
Based on 11 analysts
Based on 11 analysts
Analysts rate NEO Buy, with 8 of 11 recommending Buy or Strong buy.
Neogenomics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NEO's stock price target?
Price Target
22.44
USD
22.44
USD
According to Wall Street analysts, the average 1-year price target for NEO is 22.44 USD with a low forecast of 19.19 USD and a high forecast of 36.75 USD.
What is the Revenue forecast for Neogenomics Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Neogenomics Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 5 years is 12%.
